Influence of interferon-alpha on lymphocyte subpopulations in Behçet's disease.
Treusch
Michaela
M
University Hospital, Department of Internal Medicine II (Hematology, Oncology, Immunology, Rheumatology), Tübingen, Germany.
Stübiger
Nicole
N
Vonthein
Reinhard
R
Baur
Manuela
M
Koch
Silvia
S
Günaydin
Ilhan
I
Kanz
Lothar
L
Zierhut
Manfred
M
Kötter
Ina
I
D000328:Adult; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D015703:Antigens, CD / Q000097:blood; D001528:Behcet Syndrome / Q000188:drug therapy* / Q000276:immunology; D005260:Female; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D007694:Killer Cells, Natural / Q000187:drug effects / Q000276:immunology; D018655:Lymphocyte Count; D016131:Lymphocyte Subsets / Q000187:drug effects / Q000276:immunology*; D008297:Male; D011994:Recombinant Proteins; D012016:Reference Values; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology
D020533:Angiogenesis Inhibitors; D015703:Antigens, CD; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins